Qianjin Pharmaceutical Subsidiary Obtains Registration Certificates for Four Drugs

Corporate Action
โดย CLS·CN·Read original
Summary · why it matters

Qianjin Pharmaceutical announced that its subsidiaries Qianjin Xiangjiang Pharmaceutical and Qianjin Xieli Pharmaceutical have received Drug Registration Certificates issued by the National Medical Products Administration for minoxidil liniment, ezetimibe tablets, amlodipine benazepril capsules, and ursodeoxycholic acid capsules.

Impact on stocks 1

Others▲ · 1 stocks
© 2026 MarketDXNews